Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Trump secures release of American trapped in Saudi...
Blue states blasted for funneling millions in SNAP...
Graham demands Democrats explain ‘refuse illegal orders’ message...
Trump not invited to Dick Cheney funeral
Zeldin, McCain hammer Crockett on Epstein donations claim
Trump’s trillion-dollar Saudi deal could reshape markets —...
Vance says Trump admin has ‘great’ healthcare plan...
White House shuts down reports US backtracked on...
US and Russia draft peace plan for Ukraine...
Schumer, Jeffries accuse Trump of calling for ‘execution...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Jackson’s scathing dissent levels partisan charge at colleagues after high-profile ruling

by admin August 23, 2025
August 23, 2025
Jackson’s scathing dissent levels partisan charge at colleagues after high-profile ruling

Justice Ketanji Brown Jackson criticized on Thursday what she said were the ‘recent tendencies’ of the Supreme Court to side with the Trump administration, providing her remarks in a bitter dissent in a case related to National Institutes of Health grants.

Jackson, a Biden appointee, rebuked her colleagues for ‘lawmaking’ on the shadow docket, where an unusual volume of fast, preliminary decision-making has taken place related to the hundreds of lawsuits President Donald Trump’s administration has faced.

‘This is Calvinball jurisprudence with a twist. Calvinball has only one rule: There are no fixed rules. We seem to have two: that one, and this Administration always wins,’ Jackson wrote.

The liberal justice pointed to the Oxford English Dictionary’s definition of Calvinball, which describes it as the practice of applying rules inconsistently for self-serving purposes.

Jackson, the high court’s most junior justice, said the majority ‘[bent] over backwards to accommodate’ the Trump administration by allowing the NIH to cancel about $783 million in grants that did not align with the administration’s priorities.

Some of the grants were geared toward research on diversity, equity and inclusion; COVID-19; and gender identity. Jackson argued the grants went far beyond that and that ‘life-saving biomedical research’ was at stake.

‘So, unfortunately, this newest entry in the Court’s quest to make way for the Executive Branch has real consequences, for the law and for the public,’ Jackson wrote.

The Supreme Court’s decision was fractured and only a partial victory for the Trump administration.

In a 5-4 decision greenlighting, for now, the NIH’s existing grant cancellations, Chief Justice John Roberts sided with the three liberal justices. In a second 5-4 decision that keeps a lower court’s block on the NIH’s directives about the grants intact, Justice Amy Coney Barrett, a Trump appointee, sided with Roberts and the three liberals. The latter portion of the ruling could hinder the NIH’s ability to cancel future grants.

The varying opinions by the justices came out to 36 pages total, which is lengthy relative to other emergency rulings. Jackson’s dissent made up more than half of that.

George Washington University law professor Jonathan Turley observed in an op-ed last month a rise in ‘rhetoric’ from Jackson, who garnered a reputation as the most vocal justice during oral arguments upon her ascension to the high court.

‘The histrionic and hyperbolic rhetoric has increased in Jackson’s opinions, which at times portray her colleagues as abandoning not just the Constitution but democracy itself,’ Turley said.

Barrett had sharp words for Jackson in a recent highly anticipated decision in which the Supreme Court blocked lower courts from imposing universal injunctions on the government. Barrett accused Jackson of subscribing to an ‘imperial judiciary’ and instructed people not to ‘dwell’ on her colleague’s dissent.

Barrett, the lone justice to issue the split decision in the NIH case, said challenges to the grants should be brought by the grant recipients in the Court of Federal Claims.

But Barrett said ‘both law and logic’ support that the federal court in Massachusetts does have the authority to review challenges to the guidance the NIH issued about grant money. Barrett joined Jackson and the other three in denying that portion of the Trump administration’s request, though she said she would not weigh in at this early stage on the merits of the case as it proceeds through the lower courts.

Jackson was dissatisfied with this partial denial of the Trump administration’s request, saying it was the high court’s way of preserving the ‘mirage of judicial review while eliminating its purpose: to remedy harms.’

This post appeared first on FOX NEWS

previous post
GOP senators push Kamala Harris testimony as House Oversight eyes subpoena
next post
10 key takeaways from DOJ’s release of Ghislaine Maxwell’s Epstein interviews

You may also like

SCOOP: House GOP memo highlights Republican wins in...

May 23, 2025

MIKE DAVIS: Justice is coming for perpetrators of...

November 1, 2025

Conservative group debuts major ad buy in key...

December 13, 2024

Musk offers ‘another chance’ to respond to productivity...

February 25, 2025

Trump ups his ante with September fundraising haul

October 3, 2024

Starmer says UK to recognize Palestinian state if...

July 30, 2025

Expert warns UN’s role in AI regulation could...

October 6, 2024

VP Kamala Harris could name one of these...

July 31, 2024

Inside Putin’s mindset: What team Trump can expect...

January 6, 2025

Trump’s world leaders club: who’s in and who’s...

January 26, 2025

Recent Posts

  • Trump secures release of American trapped in Saudi Arabia for years over online posts
  • Blue states blasted for funneling millions in SNAP cash for fast-food meals
  • Graham demands Democrats explain ‘refuse illegal orders’ message to troops
  • Trump not invited to Dick Cheney funeral
  • Zeldin, McCain hammer Crockett on Epstein donations claim

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (951)
    • Investing (3,475)
    • Politics (4,239)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.